{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:18:01Z","timestamp":1791461881204,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The renin\u2013angiotensin system (RAS) plays a critical role in vascular homeostasis and inflammation, and its dysregulation has been implicated in the pathophysiology of COVID-19. We investigated the dynamics of RAS peptides and markers of endothelial dysfunction in relation to respiratory disease progression in hospitalized COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-centre prospective observational study, 155 adult patients with confirmed SARS-CoV-2 infection were enrolled at hospital admission. Plasma levels of renin, angiotensin I (Ang I), angiotensin II (Ang II), angiotensin 1\u20137 (Ang 1\u20137), the Ang II\/Ang I ratio (as a surrogate of ACE activity), and asymmetric dimethylarginine (ADMA)\u2014a marker of endothelial dysfunction \u2014were measured at baseline (D0) and day 3 (D3). Endothelial injury was further assessed using the Endothelial Activation and Stress Index (EASIX). Patients were stratified by respiratory trajectory using the WHO ordinal scale. Biomarker kinetics were analysed with baseline-adjusted regression models, and 28-day clinical status was evaluated using partial proportional-odds regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 155 patients, 89 (57%) experienced worsening respiratory status. These patients exhibited progressive RAS activation with higher renin and Ang I at D3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), a decline in the Ang II\/Ang I ratio (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and a rise in Ang 1\u20137 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). ADMA and EASIX levels increased in parallel, with significantly higher ADMA in worsening vs. non-worsening patients at D3 (0.72 [0.62\u20130.87] vs. 0.61 [0.50\u20130.70] \u00b5M\/L;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Biomarker trajectories differed according to disease course, with significant interaction terms between baseline values and respiratory deterioration. At 28\u00a0days, outcomes were associated with renin, Ang I, Ang 1\u20137, and the Ang II\/Ang I ratio, but not with Ang II. Elevated baseline ADMA also independently predicted worse prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Worsening respiratory status in COVID-19 is associated with delayed activation of the RAS, a shift toward the alternative Ang 1\u20137 pathway, and parallel increases in endothelial dysfunction markers. These findings suggest that serial measurements of RAS peptides and ADMA may aid in identifying high-risk phenotypes and inform personalized therapeutic strategies in COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-026-00857-w","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:53:14Z","timestamp":1770691994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renin\u2013angiotensin system activation and oxidative stress in hospitalized COVID-19 patients: a single-centre prospective observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Davide","family":"Eleuteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Del Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Silvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Tucciariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Gervasoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniello","family":"Primiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernico","family":"Torelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Lucio","family":"Cutuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calabrese","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Masullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Di Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Gemelli-ICU Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo De","family":"Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Di","family":"Gravio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Giammatteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Luca","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gull\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Livanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikardo","family":"Xhemalaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ciasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"857_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00424-024-02908-1","volume":"476","author":"H Triebel","year":"2024","unstructured":"Triebel H, Castrop H (2024) The renin angiotensin aldosterone system. Pflugers Arch 476:705\u2013713. https:\/\/doi.org\/10.1007\/s00424-024-02908-1","journal-title":"Pflugers Arch"},{"key":"857_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01304-3","volume":"14","author":"Y Kotani","year":"2024","unstructured":"Kotani Y, Chappell M, Landoni G, Zarbock A, Bellomo R, Khanna AK (2024) Renin in critically ill patients. Ann Intensive Care 14:79. https:\/\/doi.org\/10.1186\/s13613-024-01304-3","journal-title":"Ann Intensive Care"},{"key":"857_CR3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S (2018) Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 98:1627\u20131738. https:\/\/doi.org\/10.1152\/physrev.00038.2017","journal-title":"Physiol Rev"},{"key":"857_CR4","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South AM, Diz DI, Chappell MC (2020) COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol 318:H1084\u2013H1090. https:\/\/doi.org\/10.1152\/ajpheart.00217.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"857_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M, Campagnole-Santos MJ (2018) The ACE2\/Angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1\u20137). Physiol Rev 98:505\u2013553. https:\/\/doi.org\/10.1152\/physrev.00023.2016","journal-title":"Physiol Rev"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","volume":"38","author":"C-H Wu","year":"2018","unstructured":"Wu C-H, Mohammadmoradi S, Chen JZ, Sawada H, Daugherty A, Lu HS (2018) Renin-angiotensin system and cardiovascular functions. Arterioscler Thromb Vasc Biol 38:e108\u2013e116. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311282","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"857_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3317\/jraas.2006.003","volume":"7","author":"CM Ferrario","year":"2006","unstructured":"Ferrario CM (2006) Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 7:3\u201314. https:\/\/doi.org\/10.3317\/jraas.2006.003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"857_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"A Khan","year":"2017","unstructured":"Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, Hall R, Poirier G, Ronco JJ, Tidswell M, Hardes K, Powley WM, Wright TJ, Siederer SK, Fairman DA, Lipson DA, Bayliffe AI, Lazaar AL (2017) A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care 21:234. https:\/\/doi.org\/10.1186\/s13054-017-1823-x","journal-title":"Crit Care"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui C-C, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436:112\u2013116. https:\/\/doi.org\/10.1038\/nature03712","journal-title":"Nature"},{"key":"857_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med 11:875\u2013879. https:\/\/doi.org\/10.1038\/nm1267","journal-title":"Nat Med"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/cells10071767","volume":"10","author":"D Laghlam","year":"2021","unstructured":"Laghlam D, Jozwiak M, Nguyen LS (2021) Renin-angiotensin-aldosterone system and immunomodulation: a state-of-the-art review. Cells 10:1767. https:\/\/doi.org\/10.3390\/cells10071767","journal-title":"Cells"},{"key":"857_CR12","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","volume":"184","author":"ML Yeung","year":"2021","unstructured":"Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai J-P, Zhou R, Chan K-H, Zhao H, Zhu L, Siu K-L, Fung S-Y, Yung S, Chan TM, To K-W, Chan J-W, Cai Z, Lau SKP, Chen Z, Jin D-Y, Woo PCY, Yuen K-Y (2021) Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system. Cell 184:2212-2228.e12. https:\/\/doi.org\/10.1016\/j.cell.2021.02.053","journal-title":"Cell"},{"key":"857_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pcad.2020.07.006","volume":"63","author":"BM Henry","year":"2020","unstructured":"Henry BM, Benoit S, Lippi G, Benoit J (2020) Letter to the editor - circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): a preliminary report. Prog Cardiovasc Dis 63:702\u2013703. https:\/\/doi.org\/10.1016\/j.pcad.2020.07.006","journal-title":"Prog Cardiovasc Dis"},{"key":"857_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01433-3","volume":"15","author":"K Krenn","year":"2025","unstructured":"Krenn K, Kraft F, Mandroiu L, Tretter V, Reindl-Schwaighofer R, Clement T, Domenig O, Vossen MG, Riemann G, Poglitsch M, Ullrich R (2025) Renin-angiotensin-aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study. Ann Intensive Care 15:10. https:\/\/doi.org\/10.1186\/s13613-025-01433-3","journal-title":"Ann Intensive Care"},{"key":"857_CR15","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00114-2021","volume":"7","author":"AL Valle Martins","year":"2021","unstructured":"Valle Martins AL, da Silva FA, Bolais-Ramos L, de Oliveira GC, Ribeiro RC, Pereira DAA, Annoni F, Diniz MML, Silva TGF, Zivianni B, Cardoso AC, Martins JC, Motta-Santos D, Campagnole-Santos MJ, Taccone FS, Verano-Braga T, Santos RAS (2021) Increased circulating levels of angiotensin-(1-7) in severely ill COVID-19 patients. ERJ Open Res 7:00114\u201302021. https:\/\/doi.org\/10.1183\/23120541.00114-2021","journal-title":"ERJ Open Res"},{"key":"857_CR16","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1097\/CCM.0000000000004967","volume":"49","author":"S Ozkan","year":"2021","unstructured":"Ozkan S, Cakmak F, Konukoglu D, Biberoglu S, Ipekci A, Akdeniz YS, Bolayirli IM, Balkan II, Dumanli GY, Ikizceli I (2021) Efficacy of serum angiotensin II levels in prognosis of patients with coronavirus disease 2019. Crit Care Med 49:e613\u2013e623. https:\/\/doi.org\/10.1097\/CCM.0000000000004967","journal-title":"Crit Care Med"},{"key":"857_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","volume":"24","author":"S Pons","year":"2020","unstructured":"Pons S, Fodil S, Azoulay E, Zafrani L (2020) The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 24:353. https:\/\/doi.org\/10.1186\/s13054-020-03062-7","journal-title":"Crit Care"},{"key":"857_CR18","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S1473-3099(20)30367-4","volume":"20","author":"M Lang","year":"2020","unstructured":"Lang M, Som A, Mendoza DP, Flores EJ, Reid N, Carey D, Li MD, Witkin A, Rodriguez-Lopez JM, Shepard J-AO, Little BP (2020) Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 20:1365\u20131366. https:\/\/doi.org\/10.1016\/S1473-3099(20)30367-4","journal-title":"Lancet Infect Dis"},{"key":"857_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323:2052\u20132059. https:\/\/doi.org\/10.1001\/jama.2020.6775","journal-title":"JAMA"},{"key":"857_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"857_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36954-z","volume":"13","author":"E Sozio","year":"2023","unstructured":"Sozio E, Hannemann J, Fabris M, Cif\u00f9 A, Ripoli A, Sbrana F, Cescutti D, Vetrugno L, Fapranzi S, Bassi F, Sponza M, Curcio F, Tascini C, B\u00f6ger R (2023) The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome. Sci Rep 13:9811. https:\/\/doi.org\/10.1038\/s41598-023-36954-z","journal-title":"Sci Rep"},{"key":"857_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89180-w","volume":"11","author":"J Hannemann","year":"2021","unstructured":"Hannemann J, Balfanz P, Schwedhelm E, Hartmann B, Ule J, M\u00fcller-Wieland D, Dahl E, Dreher M, Marx N, B\u00f6ger R (2021) Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. Sci Rep 11:9895. https:\/\/doi.org\/10.1038\/s41598-021-89180-w","journal-title":"Sci Rep"},{"key":"857_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"857_CR24","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","volume":"4","author":"T Luft","year":"2017","unstructured":"Luft T, Benner A, Jodele S, Dandoy CE, Storb R, Gooley T, Sandmaier BM, Becker N, Radujkovic A, Dreger P, Penack O (2017) Easix in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol 4:e414\u2013e423. https:\/\/doi.org\/10.1016\/S2352-3026(17)30108-4","journal-title":"Lancet Haematol"},{"key":"857_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1164\/rccm.202106-1514OC","volume":"205","author":"DE Leisman","year":"2022","unstructured":"Leisman DE, Mehta A, Thompson BT, Charland NC, Gonye ALK, Gushterova I, Kays KR, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Parry BA, Villani A-C, Sade-Feldman M, Hacohen N, Filbin MR, Goldberg MB (2022) Alveolar, endothelial, and organ injury marker dynamics in severe COVID-19. Am J Respir Crit Care Med 205:507\u2013519. https:\/\/doi.org\/10.1164\/rccm.202106-1514OC","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM (2011) Multiple imputation using chained equations: issues and guidance for practice. Stat Med 30:377\u2013399. https:\/\/doi.org\/10.1002\/sim.4067","journal-title":"Stat Med"},{"key":"857_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.2000.10474549","author":"S Long","year":"2000","unstructured":"Long S, Ervin LH (2000) Using heteroscedasticity consistent standard errors in the linear regression model. Am Stat. https:\/\/doi.org\/10.1080\/00031305.2000.10474549","journal-title":"Am Stat"},{"key":"857_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044486","volume":"11","author":"P Svensson","year":"2021","unstructured":"Svensson P, Hofmann R, H\u00e4bel H, Jernberg T, Nordberg P (2021) Association between cardiometabolic disease and severe COVID-19: a nationwide case\u2013control study of patients requiring invasive mechanical ventilation. BMJ Open 11:e044486. https:\/\/doi.org\/10.1136\/bmjopen-2020-044486","journal-title":"BMJ Open"},{"key":"857_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1213\/ANE.0000000000006682","volume":"138","author":"Y Kotani","year":"2024","unstructured":"Kotani Y, Belletti A, Maiucci G, Lodovici M, Fresilli S, Landoni G, Bellomo R, Zarbock A (2024) Renin as a prognostic marker in intensive care and perioperative settings: a scoping review. Anesth Analg 138:929\u2013936. https:\/\/doi.org\/10.1213\/ANE.0000000000006682","journal-title":"Anesth Analg"},{"key":"857_CR30","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","volume":"202","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, H\u00e4stbacka J, Khanna AK, Albertson TE, Tumlin J, Storey K, Handisides D, Tidmarsh GF, Chawla LS, Ostermann M (2020) Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med 202:1253\u20131261. https:\/\/doi.org\/10.1164\/rccm.201911-2172OC","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03725-z","volume":"25","author":"AH Flannery","year":"2021","unstructured":"Flannery AH, Ortiz-Soriano V, Li X, Gianella FG, Toto RD, Moe OW, Devarajan P, Goldstein SL, Neyra JA (2021) Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study. Crit Care 25:294. https:\/\/doi.org\/10.1186\/s13054-021-03725-z","journal-title":"Crit Care"},{"key":"857_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/CCM.0000000000006095","volume":"52","author":"LW Busse","year":"2024","unstructured":"Busse LW, Schaich CL, Chappell MC, McCurdy MT, Staples EM, Ten Lohuis CC, Hinson JS, Sevransky JE, Rothman RE, Wright DW, Martin GS, Khanna AK, Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Investigators (2024) Association of active renin content with mortality in critically ill patients: a post hoc analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) trial. Crit Care Med 52:441\u2013451. https:\/\/doi.org\/10.1097\/CCM.0000000000006095","journal-title":"Crit Care Med"},{"key":"857_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","volume":"50","author":"M Jeyaraju","year":"2022","unstructured":"Jeyaraju M, McCurdy MT, Levine AR, Devarajan P, Mazzeffi MA, Mullins KE, Reif M, Yim DN, Parrino C, Lankford AS, Chow JH (2022) Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients. Crit Care Med 50:50\u201360. https:\/\/doi.org\/10.1097\/CCM.0000000000005143","journal-title":"Crit Care Med"},{"key":"857_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1164\/rccm.202005-2050OC","volume":"203","author":"M K\u00fcllmar","year":"2021","unstructured":"K\u00fcllmar M, Saadat-Gilani K, Weiss R, Massoth C, Lagan A, Cort\u00e9s MN, Gerss J, Chawla LS, Fliser D, Meersch M, Zarbock A (2021) Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients. Am J Respir Crit Care Med 203:1119\u20131126. https:\/\/doi.org\/10.1164\/rccm.202005-2050OC","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","volume":"47","author":"PJ Gleeson","year":"2019","unstructured":"Gleeson PJ, Crippa IA, Mongkolpun W, Cavicchi FZ, Van Meerhaeghe T, Brimioulle S, Taccone FS, Vincent J-L, Creteur J (2019) Renin as a marker of tissue-perfusion and prognosis in critically ill patients. Crit Care Med 47:152\u2013158. https:\/\/doi.org\/10.1097\/CCM.0000000000003544","journal-title":"Crit Care Med"},{"key":"857_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46:586\u2013590. https:\/\/doi.org\/10.1007\/s00134-020-05985-9","journal-title":"Intensive Care Med"},{"key":"857_CR37","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41467-021-22713-z","volume":"12","author":"S Rysz","year":"2021","unstructured":"Rysz S, Al-Saadi J, Sj\u00f6str\u00f6m A, Farm M, Campoccia Jalde F, Platt\u00e9n M, Eriksson H, Klein M, Vargas-Paris R, Nyr\u00e9n S, Abdula G, Ouellette R, Granberg T, Jonsson Fagerlund M, Lundberg J (2021) COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system. Nat Commun 12:2417. https:\/\/doi.org\/10.1038\/s41467-021-22713-z","journal-title":"Nat Commun"},{"key":"857_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213096","volume":"14","author":"R Reddy","year":"2019","unstructured":"Reddy R, Asante I, Liu S, Parikh P, Liebler J, Borok Z, Rodgers K, Baydur A, Louie SG (2019) Circulating angiotensin peptides levels in acute respiratory distress syndrome correlate with clinical outcomes: a pilot study. PLoS One 14:e0213096. https:\/\/doi.org\/10.1371\/journal.pone.0213096","journal-title":"PLoS One"},{"key":"857_CR39","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1164\/rccm.201912-2504LE","volume":"202","author":"K Krenn","year":"2020","unstructured":"Krenn K, H\u00f6bart P, Poglitsch M, Croiz\u00e9 A, Ullrich R (2020) Equilibrium angiotensin metabolite profiling in patients with acute respiratory distress syndrome indicates angiotensin-converting enzyme inhibition. Am J Respir Crit Care Med 202:1468\u20131471. https:\/\/doi.org\/10.1164\/rccm.201912-2504LE","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2733-x","volume":"24","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Wunderink RG, Szerlip H, English SW, Busse LW, Deane AM, Khanna AK, McCurdy MT, Ostermann M, Young PJ, Handisides DR, Chawla LS, Tidmarsh GF, Albertson TE (2020) Angiotensin i and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Crit Care 24:43. https:\/\/doi.org\/10.1186\/s13054-020-2733-x","journal-title":"Crit Care"},{"key":"857_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01463-x","volume":"15","author":"C Benaroua","year":"2025","unstructured":"Benaroua C, Pucci F, Rooman M, Picod A, Favory R, Legrand M, Vincent J-L, Creteur J, Taccone FS, Annoni F, Garcia B (2025) Alterations in the renin-angiotensin system during septic shock. Ann Intensive Care 15:40. https:\/\/doi.org\/10.1186\/s13613-025-01463-x","journal-title":"Ann Intensive Care"},{"key":"857_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04518-2","volume":"27","author":"N Pode-Shakked","year":"2023","unstructured":"Pode-Shakked N, Ceschia G, Rose JE, Goldstein SL, Stanski NL, Genomics of Pediatric Septic Shock Investigators (2023) Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock. Crit Care 27:230. https:\/\/doi.org\/10.1186\/s13054-023-04518-2","journal-title":"Crit Care"},{"key":"857_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001163","volume":"6","author":"B Garcia","year":"2024","unstructured":"Garcia B, Ter Schiphorst B, Su F, Picod A, Ikenna-Uba T, Favory R, Annoni F, Mebazaa A, Vincent J-L, Creteur J, Taccone FS, Herpain A (2024) Alterations in the renin-angiotensin system in experimental septic shock. Crit Care Explor 6:e1163. https:\/\/doi.org\/10.1097\/CCE.0000000000001163","journal-title":"Crit Care Explor"},{"key":"857_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","volume":"203","author":"A Picod","year":"2021","unstructured":"Picod A, Deniau B, Vaittinada Ayar P, Genest M, Julian N, Azibani F, Mebazaa A (2021) Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3. Am J Respir Crit Care Med 203:526\u2013527. https:\/\/doi.org\/10.1164\/rccm.202010-3873LE","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","volume":"383","author":"GI Rice","year":"2004","unstructured":"Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383:45\u201351. https:\/\/doi.org\/10.1042\/BJ20040634","journal-title":"Biochem J"},{"key":"857_CR46","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1164\/rccm.202012-4461OC","volume":"204","author":"L Gerard","year":"2021","unstructured":"Gerard L, Lecocq M, Bouzin C, Hoton D, Schmit G, Pereira JP, Montiel V, Plante-Bordeneuve T, Laterre P-F, Pilette C (2021) Increased angiotensin-converting enzyme 2 and loss of alveolar type II cells in COVID-19-related acute respiratory distress syndrome. Am J Respir Crit Care Med 204:1024\u20131034. https:\/\/doi.org\/10.1164\/rccm.202012-4461OC","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR47","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","volume":"203","author":"R Reindl-Schwaighofer","year":"2021","unstructured":"Reindl-Schwaighofer R, H\u00f6dlmoser S, Eskandary F, Poglitsch M, Bonderman D, Strassl R, Aberle JH, Oberbauer R, Zoufaly A, Hecking M (2021) ACE2 elevation in severe COVID-19. Am J Respir Crit Care Med 203:1191\u20131196. https:\/\/doi.org\/10.1164\/rccm.202101-0142LE","journal-title":"Am J Respir Crit Care Med"},{"key":"857_CR48","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03730-2020","volume":"57","author":"SK Patel","year":"2021","unstructured":"Patel SK, Juno JA, Lee WS, Wragg KM, Hogarth PM, Kent SJ, Burrell LM (2021) Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. Eur Respir J 57:2003730. https:\/\/doi.org\/10.1183\/13993003.03730-2020","journal-title":"Eur Respir J"},{"key":"857_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252799","volume":"16","author":"TW Kragstrup","year":"2021","unstructured":"Kragstrup TW, Singh HS, Grundberg I, Nielsen A-L, Rivellese F, Mehta A, Goldberg MB, Filbin MR, Qvist P, Bibby BM (2021) Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients. PLoS One 16:e0252799. https:\/\/doi.org\/10.1371\/journal.pone.0252799","journal-title":"PLoS One"},{"key":"857_CR50","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, Feldman J, Muus C, Wadsworth MH, Kazer SW, Hughes TK, Doran B, Gatter GJ, Vukovic M, Taliaferro F, Mead BE, Guo Z, Wang JP, Gras D, Plaisant M, Ansari M, Angelidis I, Adler H, Sucre JMS, Taylor CJ, Lin B, Waghray A, Mitsialis V, Dwyer DF, Buchheit KM, Boyce JA, Barrett NA, Laidlaw TM, Carroll SL, Colonna L, Tkachev V, Peterson CW, Yu A, Zheng HB, Gideon HP, Winchell CG, Lin PL, Bingle CD, Snapper SB, Kropski JA, Theis FJ, Schiller HB, Zaragosi L-E, Barbry P, Leslie A, Kiem H-P, Flynn JL, Fortune SM, Berger B, Finberg RW, Kean LS, Garber M, Schmidt AG, Lingwood D, Shalek AK, Ordovas-Montanes J, HCA Lung Biological Network, HCA Lung Biological Network (2020) SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181:1016-1035.e19. https:\/\/doi.org\/10.1016\/j.cell.2020.04.035","journal-title":"Cell"},{"key":"857_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals M, Huisman MV, Endeman H (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148\u2013150. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.041","journal-title":"Thromb Res"},{"issue":"8","key":"857_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua G, Pine AB, Meizlish ML, Chang C-H, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7(8):e575. https:\/\/doi.org\/10.1016\/S2352-3026(20)30216-7","journal-title":"Lancet Haematol"},{"key":"857_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383:120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432","journal-title":"N Engl J Med"},{"key":"857_CR54","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"key":"857_CR55","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","volume":"396","author":"S Narula","year":"2020","unstructured":"Narula S, Yusuf S, Chong M, Ramasundarahettige C, Rangarajan S, Bangdiwala SI, van Eikels M, Leineweber K, Wu A, Pigeyre M, Par\u00e9 G (2020) Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis. Lancet 396:968\u2013976. https:\/\/doi.org\/10.1016\/S0140-6736(20)31964-4","journal-title":"Lancet"},{"key":"857_CR56","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/eurheartj\/ehn360","volume":"29","author":"WHW Tang","year":"2008","unstructured":"Tang WHW, Tong W, Shrestha K, Wang Z, Levison BS, Delfraino B, Hu B, Troughton RW, Klein AL, Hazen SL (2008) Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J 29:2506\u20132513. https:\/\/doi.org\/10.1093\/eurheartj\/ehn360","journal-title":"Eur Heart J"},{"key":"857_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01369-0","volume":"14","author":"ALV Martins","year":"2024","unstructured":"Martins ALV, Annoni F, da Silva FA, Bolais-Ramos L, de Oliveira GC, Ribeiro RC, Diniz MML, Silva TGF, Pinheiro BD, Rodrigues NA, Dos Santos Matos AH, Motta-Santos D, Campagnole-Santos MJ, Verano-Braga T, Taccone FS, Santos RAS (2024) Angiotensin-(1-7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1-2 randomized clinical trial. Ann Intensive Care 14:139. https:\/\/doi.org\/10.1186\/s13613-024-01369-0","journal-title":"Ann Intensive Care"},{"key":"857_CR58","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jama.2023.3546","volume":"329","author":"WH Self","year":"2023","unstructured":"Self WH, Shotwell MS, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine N, Tiffany B, Douglas IS, Levitt J, Busse LW, Ginde AA, Brown SM, Hager DN, Boyle K, Duggal A, Khan A, Lanspa M, Chen P, Puskarich M, Vonderhaar D, Venkateshaiah L, Gentile N, Rosenberg Y, Troendle J, Bistran-Hall AJ, DeClercq J, Lavieri R, Joly MM, Orr M, Pulley J, Rice TW, Schildcrout JS, Semler MW, Wang L, Bernard GR, Collins SP, ACTIV-4 Host Tissue Investigators (2023) Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor-biased ligand in adults with COVID-19: two randomized clinical trials. JAMA 329:1170\u20131182","journal-title":"JAMA"},{"key":"857_CR59","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ehf2.13787","volume":"9","author":"M Lenz","year":"2022","unstructured":"Lenz M, Krychtiuk KA, Brekalo M, Draxler DF, Pavo N, Hengstenberg C, Huber K, H\u00fclsmann M, Heinz G, Wojta J, Speidl WS (2022) Soluble neprilysin and survival in critically ill patients. ESC Heart Fail 9:1160\u20131166. https:\/\/doi.org\/10.1002\/ehf2.13787","journal-title":"ESC Heart Fail"},{"key":"857_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24628-1","volume":"12","author":"R Reindl-Schwaighofer","year":"2022","unstructured":"Reindl-Schwaighofer R, H\u00f6dlmoser S, Domenig O, Krenn K, Eskandary F, Krenn S, Sch\u00f6rgenhofer C, Rumpf B, Karolyi M, Traugott MT, Abrahamowicz A, Tinhof V, Mayfurth H, Rathkolb V, Mu\u00dfnig S, Schm\u00f6lz L, Ullrich R, Heinzel A, K\u00f6nig F, Binder C, Bonderman D, Strassl R, Puchhammer-St\u00f6ckl E, Gorkiewicz G, Aberle JH, Jilma B, Wenisch C, Poglitsch M, Oberbauer R, Zoufaly A, Hecking M (2022) The systemic renin-angiotensin system in COVID-19. Sci Rep 12:20117. https:\/\/doi.org\/10.1038\/s41598-022-24628-1","journal-title":"Sci Rep"},{"key":"857_CR61","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM, Turner AJ (2005) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280:30113\u201330119. https:\/\/doi.org\/10.1074\/jbc.M505111200","journal-title":"J Biol Chem"},{"key":"857_CR62","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/HYPERTENSIONAHA.120.16724","volume":"77","author":"MC Chappell","year":"2021","unstructured":"Chappell MC, Pirro NT, South AM, Gwathmey TM (2021) Concerns on the specificity of commercial ELISAs for the measurement of angiotensin (1\u20137) and angiotensin II in human plasma. Hypertension 77:e29\u2013e31. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16724","journal-title":"Hypertension"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00857-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:27:25Z","timestamp":1770737245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00857-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00857-w","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Fondazione Policlinico Universitario A. Gemelli IRCCS (approval number 3899; protocol number 0013481\/21, issued in April 2021). All patients, or their legal representatives where applicable, provided written informed consent prior to inclusion in the study, in accordance with national law and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"15"}}